Literature DB >> 32336678

Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.

Matthew P Cheng1, Todd C Lee1, Darrell H S Tan1, Srinivas Murthy2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32336678      PMCID： PMC7162442          DOI： 10.1503/cmaj.200438

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  14 in total

1.  Participation of more community hospitals in randomized trials of treatments for COVID-19 is needed.

Authors:  Jennifer L Y Tsang; Alexandra Binnie; George Farjou; Dimitra Fleming; Maham Khalid; Erick Duan
Journal:  CMAJ       Date:  2020-05-19       Impact factor: 8.262

2. 

Authors:  Bahaa Abu-Raya; Soren Gantt; Manish Sadarangani
Journal:  CMAJ       Date:  2020-11-30       Impact factor: 8.262

3.  Recommendations for use of the diverse tests for detection of SARS-COV-2 infection.

Authors:  Lidia Gestoso-Pecellín; Yuneysa García-Flores; Pino González-Quintana; José Luis Marrero-Arencibia
Journal:  Enferm Clin       Date:  2020-10-14

4.  Impact of COVID-19 on pediatric clinical research in France.

Authors:  Florence Flamein; Frederic Gottrand; Maya Laxmi Patel; Régis Hankard
Journal:  CMAJ       Date:  2020-05-25       Impact factor: 8.262

5.  Sample sizes in COVID-19-related research.

Authors:  Paul H Lee
Journal:  CMAJ       Date:  2020-04-27       Impact factor: 8.262

6.  Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.

Authors:  Stephen R Hanney; Sharon E Straus; Bev J Holmes
Journal:  Health Res Policy Syst       Date:  2022-09-10

Review 7.  Potential strategies for combating COVID-19.

Authors:  Saba Shamim; Maryam Khan; Zelal Jaber Kharaba; Munazza Ijaz; Ghulam Murtaza
Journal:  Arch Virol       Date:  2020-08-10       Impact factor: 2.574

8.  Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.

Authors:  Sylvain A Lother; Mahsa Abassi; Alyssa Agostinis; Ananta S Bangdiwala; Matthew P Cheng; Glen Drobot; Nicole Engen; Kathy H Hullsiek; Lauren E Kelly; Todd C Lee; Sarah M Lofgren; Lauren J MacKenzie; Nicole Marten; Emily G McDonald; Elizabeth C Okafor; Katelyn A Pastick; Matthew F Pullen; Radha Rajasingham; Ilan Schwartz; Caleb P Skipper; Alexis F Turgeon; Ryan Zarychanski; David R Boulware
Journal:  Can J Anaesth       Date:  2020-05-07       Impact factor: 6.713

Review 9.  Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review.

Authors:  Matthew P Cheng; Jesse Papenburg; Michaël Desjardins; Sanjat Kanjilal; Caroline Quach; Michael Libman; Sabine Dittrich; Cedric P Yansouni
Journal:  Ann Intern Med       Date:  2020-04-13       Impact factor: 25.391

10.  Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.

Authors:  Sarah M Lofgren; Melanie R Nicol; Ananta S Bangdiwala; Katelyn A Pastick; Elizabeth C Okafor; Caleb P Skipper; Matthew F Pullen; Nicole W Engen; Mahsa Abassi; Darlisha A Williams; Alanna A Nascene; Margaret L Axelrod; Sylvain A Lother; Lauren J MacKenzie; Glen Drobot; Nicole Marten; Matthew P Cheng; Ryan Zarychanski; Ilan S Schwartz; Michael Silverman; Zain Chagla; Lauren E Kelly; Emily G McDonald; Todd C Lee; Kathy H Hullsiek; David R Boulware; Radha Rajasingham
Journal:  Open Forum Infect Dis       Date:  2020-10-19       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.